Running from November 8-9, 2021 in Miami, Wonderland was an impressive collection of scientists and researchers, investors and entrepreneurs, therapists and patients, government officials, and media — all championing the growth of the psychedelic medicine industry.
From heavyweight celebrities like Mike Tyson, to the industry’s top companies and insiders, Wonderland was the sector’s largest in-person event. The psychedelic medicine industry has officially arrived and we’re proud to be a part of it.
Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry.
Here’s a summary of Platinum Sponsor Wake Network and their participation at Wonderland.
In addition to their generous financial support, Wake Network also participated in an important industry panel:
“Precision Medicine and Psychedelics”
About the panel: Olga Chernoloz, PhD, Chief Scientific Officer for Wake Network gave an informative presentation, asking and answering questions like:
1. Are psychedelics a panacea and what does blood have to do with it?
2. What is precision medicine and why does it matter?
3. Our genetics don’t tell the full picture.
4. Flamingos are instagram worthy.
6. How Wake will precision guide psychedelics for you.
Olga Chernoloz, PhD, Chief Scientific Officer
With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr. Chernoloz, leads R&D programs, runs feasibility analyses and optimizes business development strategy taking into consideration scientific and regulatory underpinnings. She has developed and delivered educational modules for medical and adult psychedelic space in both academic and business settings.
About the sponsor:
Wake Network is a vertically integrated fungi medicine company focused on addressing the most critical mental health challenges facing the world today and tomorrow. The Wake Network’s industry leading cultivation and approach to novel clinical research with fungus based substances is all backed by their compliance focused virtual wellness platform. The Wake Network is a decentralized international fungus company with operating facilities in Canada, Jamaica and the USA.fungus psychedelics psychedelic investors wake network research
Getting Ahead of the Psychedelics Supply Crunch
UK’s medical pot industry could reach £1.2B through reform: report
Cybin Gets FDA Approval For New Phase 2 Trial
CBD, ‘Snake Oil’ or Life-Changing?
New Study Shows Mushrooms Can Reverse Alcohol Brain Damage
Cell wall remodeling enables fungal network development in grasses
Are Reopening Penny Stocks Worth Buying After the Market Crash?
BigID Announces Auto-Discovery Apps For Cloud At AWS Re:Invent
Compass Phase 2 Study Shows Positive Results For TRD
Common antidepressant escitalopram and psilocybin can be taken together safely: study
Public Companies10 hours ago
Bright Minds Bioscience: A Deep Dive
Psilocybin11 hours ago
Florida Lawmaker Files Bill to Decriminalize All Drugs
Markets & Investing8 hours ago
Microdose Psychedelic Capital: Ethics in Psychedelics
Psychedelics8 hours ago
Psychedelic Titans with Larry Zeifman of Zeifmans LLP
Psilocybin15 hours ago
AREV Life Sciences / Absolem JV Receives Extraction Results
Psilocybin13 hours ago
Magic Mushrooms for Mental Health: A Look at Anxiety, Depression, and Bi-Polar Disorder
MDMA5 hours ago
Rick Doblin Explains MAPS’ New $70 Million Investment Fund With Vine Ventures
Law & Regulation4 hours ago
THC biomarkers ‘poor’ indicators of impairment, study shows